{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:09:42Z","timestamp":1793984982731,"version":"4.8.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100014131","name":"McGill University Health Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000109","name":"Prostate Cancer Canada","doi-asserted-by":"publisher","award":["T2014.01"],"award-info":[{"award-number":["T2014.01"]}],"id":[{"id":"10.13039\/501100000109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008719","name":"Movember Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jmoldx.2020.07.003","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T12:42:06Z","timestamp":1596544926000},"page":"1246-1263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification\u2013Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4954-2738","authenticated-orcid":false,"given":"Walead","family":"Ebrahimizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7229-3952","authenticated-orcid":false,"given":"Karl-Philippe","family":"Gu\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaghayegh","family":"Rouzbeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh M.","family":"Bramhecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9412-7763","authenticated-orcid":false,"given":"Eleonora","family":"Scarlata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Brimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak G.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Jamaspishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armen G.","family":"Aprikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5985-3698","authenticated-orcid":false,"given":"David","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.S.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4586-8052","authenticated-orcid":false,"given":"Jacques","family":"Lapointe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2020.07.003_bib1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib2","series-title":"Canadian Cancer Statistics 2018","year":"2018"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib4","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2017.7248","article-title":"The diagnosis and treatment of prostate cancer: a review","volume":"317","author":"Litwin","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib5","first-page":"299","article-title":"Closing the controversies gap in prostate cancer?","volume":"11","author":"Hutchinson","year":"2014","journal-title":"Nat Rev"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib6","doi-asserted-by":"crossref","first-page":"65566","DOI":"10.18632\/oncotarget.19217","article-title":"PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort","volume":"8","author":"Lotan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.juro.2015.09.072","article-title":"Impact of the cell cycle progression test on physician and patient treatment selection for localized prostate cancer","volume":"195","author":"Shore","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib8","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1186\/1471-2164-14-690","article-title":"Analytical validation of the oncotype DX prostate cancer assay\u2014a clinical RT-PCR assay optimized for prostate needle biopsies","volume":"14","author":"Knezevic","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib9","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1200\/JCO.2016.70.2811","article-title":"Individual patient-level meta-analysis of the performance of the decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease","volume":"35","author":"Spratt","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrg1767","article-title":"Structural variation in the human genome","volume":"7","author":"Feuk","year":"2006","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib11","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1101\/gr.140301.112","article-title":"Functional genomic analysis of chromosomal aberrations in a compendium of 8000 cancer genomes","volume":"23","author":"Kim","year":"2013","journal-title":"Genome Res"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nature20788","article-title":"Genomic hallmarks of localized, non-indolent prostate cancer","volume":"541","author":"Fraser","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib14","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cell.2018.03.029","article-title":"The evolutionary landscape of localized prostate cancers drives clinical aggression","volume":"173","author":"Espiritu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib15","doi-asserted-by":"crossref","first-page":"8504","DOI":"10.1158\/0008-5472.CAN-07-0673","article-title":"Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis","volume":"67","author":"Lapointe","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/gcc.20888","article-title":"Relative 8q gain predicts disease-specific survival irrespective of the TMPRSS2-ERG fusion status in diagnostic biopsies of prostate cancer","volume":"50","author":"Barros-Silva","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41379-018-0107-6","article-title":"The combination of PTEN deletion and 16p13.3 gain in prostate cancer provides additional prognostic information in patients treated with radical prostatectomy","volume":"32","author":"Bramhecha","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib19","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/ijc.28784","article-title":"Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer","volume":"135","author":"Kluth","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajpath.2012.04.026","article-title":"Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer","volume":"181","author":"Krohn","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/modpathol.3880487","article-title":"Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression","volume":"15","author":"Qian","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib22","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.bjc.6603924","article-title":"FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome","volume":"97","author":"Yoshimoto","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib23","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1002\/cncr.26729","article-title":"Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy","volume":"118","author":"Zafarana","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib24","doi-asserted-by":"crossref","first-page":"11139","DOI":"10.1073\/pnas.1411446111","article-title":"Copy number alteration burden predicts prostate cancer relapse","volume":"111","author":"Hieronymus","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib25","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1002\/ijc.29613","article-title":"Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer","volume":"137","author":"Kluth","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib26","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S1470-2045(14)71021-6","article-title":"Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study","volume":"15","author":"Lalonde","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-1-61779-507-7_15","article-title":"Targeted screening and validation of copy number variations","volume":"838","author":"Ceulemans","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.humpath.2018.10.017","article-title":"Amplicons in breast cancers analyzed by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization","volume":"85","author":"Ooi","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib29","series-title":"The Retinoblastoma Protein","first-page":"7","article-title":"Detection of RB1 gene copy number variations using a multiplex ligation-dependent probe amplification method","author":"Dalay","year":"2018"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib31","doi-asserted-by":"crossref","first-page":"e0179732","DOI":"10.1371\/journal.pone.0179732","article-title":"Reliability and performance of commercial RNA and DNA extraction kits for FFPE tissue cores","volume":"12","author":"Patel","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13039-014-0075-6","article-title":"Investigation of selected genomic deletions and duplications in a cohort of 338 patients presenting with syndromic obesity by multiplex ligation-dependent probe amplification using synthetic probes","volume":"7","author":"D'Angelo","year":"2014","journal-title":"Mol Cytogenet"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2144\/04373ST04","article-title":"Multiplex ligation-dependent probe amplification using a completely synthetic probe set","volume":"37","author":"Stern","year":"2004","journal-title":"Biotechniques"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1399-0004.2008.00980.x","article-title":"Gene dosage imbalances in patients with 46,XY gonadal DSD detected by an in-house-designed synthetic probe set for multiplex ligation-dependent probe amplification analysis","volume":"73","author":"Barbaro","year":"2008","journal-title":"Clin Genet"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/1471-2407-12-543","article-title":"PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity","volume":"12","author":"Choucair","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eururo.2018.11.045","article-title":"Compound genomic alterations of TP53, PTEN, and RB1 tumor suppressors in localized and metastatic prostate cancer","volume":"76","author":"Hamid","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib37","doi-asserted-by":"crossref","first-page":"27966","DOI":"10.18632\/oncotarget.4626","article-title":"Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer","volume":"6","author":"Kluth","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib38","first-page":"5652","article-title":"Identification of 12p as a region of frequent deletion in advanced prostate cancer","volume":"58","author":"Kibel","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib39","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/gcc.22645","article-title":"13q Deletion is linked to an adverse phenotype and poor prognosis in prostate cancer","volume":"57","author":"Kluth","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1593\/tlo.12286","article-title":"The 16p13.3 (PDPK1) genomic gain in prostate cancer: a potential role in disease progression","volume":"5","author":"Choucair","year":"2012","journal-title":"Transl Oncol"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1158\/1541-7786.MCR-17-0270","article-title":"Genomic gain of 16p13.3 in prostate cancer predicts poor clinical outcome after surgical intervention","volume":"16","author":"Bramhecha","year":"2018","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib42","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1158\/0008-5472.CAN-12-1342","article-title":"CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer","volume":"73","author":"Burkhardt","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib43","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1038\/onc.2011.590","article-title":"Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness","volume":"31","author":"Huang","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib44","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1158\/0008-5472.CAN-14-1596","article-title":"Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer","volume":"75","author":"Rodrigues","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib45","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib46","doi-asserted-by":"crossref","first-page":"8337","DOI":"10.1158\/0008-5472.CAN-06-1482","article-title":"TMPRSS2: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer","volume":"66","author":"Perner","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib47","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1038\/sj.onc.1210237","article-title":"TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort","volume":"26","author":"Demichelis","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib48","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/1471-2164-9-407","article-title":"Human MLPA Probe Design (H-MAPD): a probe design tool for both electrophoresis-based and bead-coupled human multiplex ligation-dependent probe amplification assays","volume":"9","author":"Zhi","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib49","doi-asserted-by":"crossref","first-page":"bay119","DOI":"10.1093\/database\/bay119","article-title":"Ensembl variation resources","volume":"2018","author":"Hunt","year":"2018","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib50","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/pros.20158","article-title":"Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines","volume":"63","author":"Zhao","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib53","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib54","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/nar\/26.11.2797","article-title":"The influence of fluorescent dye structure on the electrophoretic mobility of end-labeled DNA","volume":"26","author":"Tu","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/pros.2990230206","article-title":"p53 Oncogene mutations in three human prostate cancer cell lines","volume":"23","author":"Carroll","year":"1993","journal-title":"Prostate"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib56","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1073\/pnas.95.9.5246","article-title":"Inactivation of the tumor suppressor PTEN\/MMAC1 in advanced human prostate cancer through loss of expression","volume":"95","author":"Whang","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41241-016-0007-3","article-title":"Utilization of the oncoscan microarray assay in cancer diagnostics","volume":"37","author":"Jung","year":"2017","journal-title":"Appl Cancer Res"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib58","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1158\/1078-0432.CCR-17-0972","article-title":"Gene copy number estimation from targeted next-generation sequencing of prostate cancer biopsies: analytic validation and clinical qualification","volume":"23","author":"Seed","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib59","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jmoldx.2017.07.004","article-title":"Clinical validation of copy number variant detection from targeted next-generation sequencing panels","volume":"19","author":"Kerkhof","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib60","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/gcc.20818","article-title":"Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia","volume":"49","author":"Schwab","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib61","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/humu.22288","article-title":"An MLPA-based strategy for discrete CNV genotyping: CNV-mi RNAs as an example","volume":"34","author":"Marcinkowska-Swojak","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib62","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/humu.20594","article-title":"MLPA screening reveals novel subtelomeric rearrangements in holoprosencephaly","volume":"28","author":"Bendavid","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib63","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1101\/gad.13.8.966","article-title":"Roles for Nkx3. 1 in prostate development and cancer","volume":"13","author":"Bhatia-Gaur","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib64","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1158\/0008-5472.CAN-03-2509","article-title":"Conditional deletion of Rb causes early stage prostate cancer","volume":"64","author":"Maddison","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib65","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3221","article-title":"Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue","volume":"47","author":"Cooper","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2020.07.003_bib66","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2217\/pgs-2018-0047","article-title":"Multi-ethnic SULT1A1 copy number profiling with multiplex ligation-dependent probe amplification","volume":"19","author":"Vijzelaar","year":"2018","journal-title":"Pharmacogenomics"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157820304268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157820304268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:14:23Z","timestamp":1761502463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157820304268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1525157820304268"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2020.07.003","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification\u2013Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2020.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}